{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:01:59Z","timestamp":1795050119015,"version":"4.10.2"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/aog.0000000000000526","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T22:37:27Z","timestamp":1415313447000},"page":"1147-1156","source":"Crossref","is-referenced-by-count":292,"title":["Vaginal Estrogen for Genitourinary Syndrome of Menopause"],"prefix":"10.1097","volume":"124","author":[{"given":"David D.","family":"Rahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Carberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana V.","family":"Sanses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta M.","family":"Mamik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate V.","family":"Meriwether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric K.","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan M.","family":"Balk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210126","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Vulvovaginal atrophy terminology consensus conference panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Womens Sexual Health and the North American Menopause Society.","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"key":"R2-12-20210126","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.maturitas.2004.06.019","article-title":"Self-reported urogenital symptoms in postmenopausal women: womens health initiative.","volume":"49","author":"Pastore","year":"2004","journal-title":"Maturitas"},{"key":"R3-12-20210126","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women.","volume":"6","author":"Santoro","year":"2009","journal-title":"J Sex Med"},{"key":"R4-12-20210126","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jsm.12190","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Womens VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J Sex Med"},{"key":"R5-12-20210126","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society.","volume":"20","year":"2013","journal-title":"Menopause"},{"key":"R6-12-20210126","first-page":"202","article-title":"Practice Bulletin No. 141. American College of Obstetricians and Gynecologists.","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R8-12-20210126","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.juro.2013.04.142","article-title":"Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials.","volume":"190","author":"Beerepoot","year":"2013","journal-title":"J Urol"},{"key":"R9-12-20210126","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/GME.0b013e318287342d","article-title":"Vaginal health in the United States: results from the Vaginal Health: Insights, Views Attitudes survey.","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"key":"R10-12-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/jwh.2007.0407","article-title":". A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice.","volume":"17","author":"Shulman","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"R12-12-20210126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2105-11-55","article-title":"Semi-automated screening of biomedical citations for systematic reviews.","volume":"11","author":"Wallace","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"R13-12-20210126","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/AOG.0b013e318232a394","article-title":". Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review.","volume":"118","author":"Rahn","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R14-12-20210126","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/AOG.0b013e3181898ba9","article-title":". Graft use in transvaginal pelvic organ prolapse repair: a systematic review.","volume":"112","author":"Sung","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R15-12-20210126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jclinepi.2009.03.009","article-title":". AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions-Agency for Healthcare Research and Quality and the effective health-care program.","volume":"63","author":"Owens","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"R16-12-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":". Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group.","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"key":"R17-12-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R18-12-20210126","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/gme.0b013e3181a48c4e","article-title":". Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.","volume":"16","author":"Bachmann","year":"2009","journal-title":"Menopause"},{"key":"R19-12-20210126","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/gme.0b013e3182518e9a","article-title":". The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005 estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.","volume":"19","author":"Cano","year":"2012","journal-title":"Menopause"},{"key":"R20-12-20210126","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/01443610120059941","article-title":"Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal womena double-blind placebo-controlled study.","volume":"21","author":"Cardozo","year":"2001","journal-title":"J Obstet Gynaecol"},{"key":"R21-12-20210126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001920050040","article-title":"Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group.","volume":"10","author":"Casper","year":"1999","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R22-12-20210126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.GME.0000077620.13164.62","article-title":". Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.","volume":"11","author":"Dessole","year":"2004","journal-title":"Menopause"},{"key":"R23-12-20210126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-2243(92)90059-8","article-title":"Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.","volume":"44","author":"Eriksen","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R24-12-20210126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-5122(91)90092-5","article-title":"Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints.","volume":"13","author":"Foidart","year":"1991","journal-title":"Maturitas"},{"key":"R25-12-20210126","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/gme.0b013e318199e734","article-title":"Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.","volume":"16","author":"Freedman","year":"2009","journal-title":"Menopause"},{"key":"R26-12-20210126","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.maturitas.2011.12.022","article-title":"Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2 mg and 0.03 mg estriol.","volume":"71","author":"Griesser","year":"2012","journal-title":"Maturitas"},{"key":"R27-12-20210126","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.","volume":"329","author":"Raz","year":"1993","journal-title":"N Engl J Med"},{"key":"R28-12-20210126","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.","volume":"112","author":"Simon","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R29-12-20210126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0020-7292(03)00200-5","article-title":"Local estrogen treatment in patients with urogenital symptoms.","volume":"82","author":"Simunic","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"R30-12-20210126","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","article-title":"A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.","volume":"180","author":"Eriksen","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R31-12-20210126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1471-0528.1996.tb09741.x","article-title":". A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.","volume":"103","author":"Ayton","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"R32-12-20210126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1068-607X(97)00001-2","article-title":"A comparative study of a low-dose estradiol vaginal ring and conjugated estrogen cream for postmenopausal urogenital atrophy.","volume":"4","author":"Bachmann","year":"1997","journal-title":"Prim Care Update"},{"issue":"suppl","key":"R33-12-20210126","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/0378-5122(95)00963-9","article-title":"Clinical trial of the estradiol vaginal ring in the U.S.","volume":"22","author":"Nachtigall","year":"1995","journal-title":"Maturitas"},{"key":"R34-12-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","article-title":"Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.","volume":"71","author":"Barentsen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R35-12-20210126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00404-011-1955-1","article-title":"Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.","volume":"285","author":"Capobianco","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R36-12-20210126","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0009-9236(98)90154-0","article-title":"The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.","volume":"64","author":"Chompootaweep","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R37-12-20210126","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/cpt1979264502","article-title":"Efficacy of estradiol vaginal cream in postmenopausal women.","volume":"26","author":"Dickerson","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"R38-12-20210126","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1034\/j.1600-0412.2000.079004293.x","article-title":"Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.","volume":"79","author":"Dugal","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R39-12-20210126","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9378(94)90074-4","article-title":"A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.","volume":"171","author":"Henriksson","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"R40-12-20210126","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0378-5122(80)90029-8","article-title":"The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects.","volume":"2","author":"Kicovic","year":"1980","journal-title":"Maturitas"},{"key":"R41-12-20210126","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1471-0528.2000.tb10408.x","article-title":"Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms.","volume":"107","author":"Lose","year":"2000","journal-title":"BJOG"},{"key":"R42-12-20210126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1447-0756.2001.tb01266.x","article-title":"The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.","volume":"27","author":"Manonai","year":"2001","journal-title":"J Obstet Gyneacol Res"},{"key":"R43-12-20210126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/00016348309154209","article-title":"A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women.","volume":"62","author":"Mattsson","year":"1983","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R44-12-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-5122(89)90213-2","article-title":"Vaginal administration of low-dose oestradioleffects on the endometrium and vaginal cytology.","volume":"11","author":"Mattsson","year":"1989","journal-title":"Maturitas"},{"key":"R45-12-20210126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0378-5122(91)90144-F","article-title":"Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets.","volume":"14","author":"Mettler","year":"1991","journal-title":"Maturitas"},{"key":"R46-12-20210126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","article-title":"17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.","volume":"7","author":"Rioux","year":"2000","journal-title":"Menopause"},{"key":"R47-12-20210126","first-page":"101","article-title":"Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.","volume":"6","author":"Trevoux","year":"1982","journal-title":"Reproduccion"},{"key":"R48-12-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":". Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"key":"R49-12-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5122(96)01087-0","article-title":"Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.","volume":"26","author":"Antoniou","year":"1997","journal-title":"Maturitas"},{"key":"R50-12-20210126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-5122(96)01070-5","article-title":"Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low-dose estrogen or tibolone treatment: a comparison.","volume":"26","author":"Botsis","year":"1997","journal-title":"Maturitas"},{"key":"R51-12-20210126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/gme.0b013e318148b98b","article-title":"The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.","volume":"15","author":"Gupta","year":"2008","journal-title":"Menopause"},{"key":"R52-12-20210126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-5122(89)90120-5","article-title":"Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy.","volume":"11","author":"Holmgren","year":"1989","journal-title":"Maturitas"},{"key":"R53-12-20210126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.fertnstert.2005.06.042","article-title":"A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women.","volume":"85","author":"Long","year":"2006","journal-title":"Fertil Steril"},{"key":"R54-12-20210126","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.gme.0000227401.98933.0b","article-title":"A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women.","volume":"13","author":"Long","year":"2006","journal-title":"Menopause"},{"key":"R55-12-20210126","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","article-title":". Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.","volume":"26","author":"Biglia","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"R56-12-20210126","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00404-010-1382-8","article-title":". The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.","volume":"283","author":"Ekin","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R57-12-20210126","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","article-title":"Comparative study: replens versus local estrogen in menopausal women.","volume":"61","author":"Nachtigall","year":"1994","journal-title":"Fertil Steril"},{"key":"R58-12-20210126","first-page":"346","article-title":". Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.","volume":"101","author":"Parsons","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R59-12-20210126","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/cmt.6.3.248.256","article-title":"Effect of raloxifene on sexual function in postmenopausal women.","volume":"6","author":"Kessel","year":"2003","journal-title":"Climacteric"},{"key":"R60-12-20210126","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1743-6109.2009.01667.x","article-title":"A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women.","volume":"7","author":"Raghunandan","year":"2010","journal-title":"J Sex Med"},{"key":"R61-12-20210126","first-page":"45","article-title":"Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.","volume":"10","author":"Pinkerton","year":"2003","journal-title":"Menopause"},{"key":"R62-12-20210126","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/374341","article-title":". Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.","volume":"36","author":"Raz","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R63-12-20210126","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/AOG.0b013e3182118790","article-title":"Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial.","volume":"117","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R64-12-20210126","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"R65-12-20210126","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/AOG.0b013e31824e12ce","article-title":"Management of gynecologic issues in women with breast cancer. Practice Bulletin No. 126. American College of Obstetricians and Gynecologists.","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R66-12-20210126","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1373\/clinchem.2003.025478","article-title":"Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma.","volume":"50","author":"Nelson","year":"2004","journal-title":"Clin Chem"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T16:53:42Z","timestamp":1717520022000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201412000-00012"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000526","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}